- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | RACURA ONCOLOGY LTD: Appendix 3Y - Dr Daniel Tillett | 1 | ASX | ||
| Do | RACURA ONCOLOGY LTD: Application for quotation of securities - RAC | 1 | ASX | ||
| Di | RACURA ONCOLOGY LTD: First Patient Recruited to HARNESS-1 Lung Cancer Trial | - | ASX | ||
| Mo | RACURA ONCOLOGY LTD: Racura Oncology Symposium Recording Release | - | ASX | ||
| 26.03. | RACURA ONCOLOGY LTD: Application for quotation of securities - RAC | 1 | ASX | ||
| 26.03. | RACURA ONCOLOGY LTD: Racura and Purdue University Partnership Announced | 1 | ASX | ||
| 24.03. | RACURA ONCOLOGY LTD: Racura Oncology Investor Symposium Presentation | - | ASX | ||
| RACURA ONCOLOGY Aktie jetzt für 0€ handeln | |||||
| 19.03. | Thursday's HotCopper trends: Racura, EVR, Immutep, and other daily topics | March 19 | 6 | The Market Herald Australia | ||
| 19.03. | RACURA ONCOLOGY LTD: Application for quotation of securities - RAC | 3 | ASX | ||
| 19.03. | Why EBR, Electro Optic Systems, Racura, and Woodside shares are rising today | 23 | The Motley Fool Australia | ||
| 18.03. | RACURA ONCOLOGY LTD: First Patient Dosed Safely with RC220 in Hong Kong | - | ASX | ||
| 17.03. | RACURA ONCOLOGY LTD: Racura Selected to Present at 2026 AACR Annual Meeting | - | ASX | ||
| 16.03. | Monday's HotCopper trends: Elixir, Lynas, Racura, and other daily topics | March 16 | 3 | The Market Herald Australia | ||
| 16.03. | Racura Oncology Advances Lung Cancer Program with HARNESS-1 Trial Approval | 1 | smallcaps.com.au | ||
| 15.03. | RACURA ONCOLOGY LTD: Racura HARNESS-1 Trial Receives Governance Approval | - | ASX | ||
| 12.03. | RACURA ONCOLOGY LTD: Application for quotation of securities - RAC | 1 | ASX | ||
| 05.03. | RACURA ONCOLOGY LTD: Application for quotation of securities - RAC | - | ASX | ||
| 03.03. | RACURA ONCOLOGY LTD: Racura Oncology Research Symposium Sydney | - | ASX | ||
| 02.03. | RACURA ONCOLOGY LTD: Racura Investor Briefing Hong Kong and Singapore | - | ASX | ||
| 27.02. | RACURA ONCOLOGY LTD: Appendix 4D & Half-Year Financial Statements | 1 | ASX |
1 2 3 4 5 Weiter >>
87 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
RACURA ONCOLOGY LTD gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 1,530 Euro und damit -1,92 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RACURA ONCOLOGY LTD finden Sie auf Wallstreet Online.